Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody

Noriko Makita(University of Occupational and Environmental Health Japan), Taroh Iiri(St. Marianna University School of Medicine)

JCI Insight

April 17, 2019

10.1172/jci.insight.126449

Cited by 17

Related Papers

Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the <scp>cAMP</scp>/Bcl‐<scp>xL</scp> pathway

|Cancer Science|2018|33

Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies

|JCI Insight|2022|9

Molecular analysis and literature-based hypothesis of an immunonegative prostate small cell carcinoma causing ectopic ACTH syndrome

|Endocrine Journal|2019|7